Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360503 · ClinicalTrials.gov registry record
Antimicrobial Resistance in Cystic Fibrosis (CF)
A clinical trial, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- 304
- Enrollment target
NCT00360503: Completed study, sponsored by Seattle Children's Hospital.
NCT00360503 is a clinical trial that has completed, run by Seattle Children's Hospital. The registered enrollment target is 304 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360503 has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
Study Summary
People with cystic fibrosis (CF) often develop chronic pulmonary infections which are caused by a variety of organisms, the most predominant being Pseudomonas aeruginosa. Antibiotics are important in managing CF lung infections. Antibiotic use in CF was altered about ten years ago with the approval of inhaled tobramycin, an aminoglycoside which is effective in treating P. aeruginosa. A decade later, CF clinicians are increasingly concerned about the likelihood of induction of aminoglycoside-resistance with prolonged use of inhaled tobramycin to treat chronic P. aeruginosa airway infections. The goal of this study is to examine the current microbiology and susceptibility of organisms from CF sputum, correlate it with antibiotic use, and compare it with previous data.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-06 |
What the finished NCT00360503 record still lists
NCT00360503 is an observational study that tracks outcomes without assigning an intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00360503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00360503 about?
NCT00360503 is a clinical study titled "Antimicrobial Resistance in Cystic Fibrosis (CF)". People with cystic fibrosis (CF) often develop chronic pulmonary infections which are caused by a variety of organisms, the most predominant being Pseudomonas aeruginosa. Antibiotics are important in managing CF lung infections. Antibiotic use in CF was altered about ten years ago with the approval ...
What is the current status of trial NCT00360503?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2006-03. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00360503?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia